• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤的血栓形成风险与管理。

Risk and management of thrombosis in multiple myeloma.

机构信息

Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.

出版信息

Thromb Res. 2012 Apr;129 Suppl 1:S88-92. doi: 10.1016/S0049-3848(12)70024-5.

DOI:10.1016/S0049-3848(12)70024-5
PMID:22682142
Abstract

Patients diagnosed with multiple myeloma have an increased risk of venous thrombosis. This may be due to various risk factors, including disease specific factors, changes in coagulation and fibrinolysis factors and circulating prothrombotic microparticles. More recent studies have indicated that also arterial thrombosis, including acute myocardial infarction and stroke do occur more frequently in these patients. Studies on etiological factors contributing to the development of thrombosis will be reviewed in this article. In addition we will focus on the prevention and management of arterial and venous thrombosis in patients with multiple myeloma.

摘要

患有多发性骨髓瘤的患者发生静脉血栓的风险增加。这可能是由于多种危险因素所致,包括疾病特异性因素、凝血和纤溶因子变化以及循环促血栓形成的微粒。最近的研究表明,这些患者也更常发生动脉血栓形成,包括急性心肌梗死和中风。本文将回顾导致血栓形成的病因学因素的研究。此外,我们将重点关注多发性骨髓瘤患者的动脉和静脉血栓形成的预防和管理。

相似文献

1
Risk and management of thrombosis in multiple myeloma.多发性骨髓瘤的血栓形成风险与管理。
Thromb Res. 2012 Apr;129 Suppl 1:S88-92. doi: 10.1016/S0049-3848(12)70024-5.
2
Thrombosis in multiple myeloma.多发性骨髓瘤中的血栓形成。
Expert Rev Anticancer Ther. 2007 Mar;7(3):307-15. doi: 10.1586/14737140.7.3.307.
3
Myeloma and thrombotic complications.多发性骨髓瘤与血栓并发症。
Minerva Med. 2013 Apr;104(2):155-60.
4
Update of thrombosis in multiple myeloma.多发性骨髓瘤血栓形成的最新进展。
Thromb Res. 2016 Apr;140 Suppl 1:S76-80. doi: 10.1016/S0049-3848(16)30103-7.
5
The evaluation and management of postnatal thromboses.产后血栓形成的评估与管理
J Perinatol. 2009 Jul;29(7):467-78. doi: 10.1038/jp.2009.14. Epub 2009 Mar 12.
6
[Treatment alternatives in mechanical valve thrombosis].[机械瓣膜血栓形成的治疗选择]
Turk Kardiyol Dern Ars. 2008 Sep;36(6):420-5.
7
Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.重组人促红细胞生成素与接受沙利度胺治疗的多发性骨髓瘤患者的血栓形成风险
Haematologica. 2004 Sep;89(9):1141-2.
8
[Thrombosis and cancer. An update of our knowledge].[血栓形成与癌症。我们知识的更新]
Tumori. 2006 Sep-Oct;92(5):23-41.
9
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.沙利度胺治疗多发性骨髓瘤患者中阿司匹林、华法林或依诺肝素预防血栓形成:一项 III 期、开放标签、随机试验。
J Clin Oncol. 2011 Mar 10;29(8):986-93. doi: 10.1200/JCO.2010.31.6844. Epub 2011 Jan 31.
10
Treatment of arterial thrombosis with low molecular weight heparins.低分子量肝素治疗动脉血栓形成
Semin Hematol. 1997 Oct;34(4 Suppl 4):26-34.

引用本文的文献

1
The Risk of Venous Thromboembolism and Ischemic Stroke Stratified by VTE Risk Following Multiple Myeloma: A Korean Population-Based Cohort Study.多发性骨髓瘤后静脉血栓栓塞风险分层的静脉血栓栓塞和缺血性卒中风险:一项基于韩国人群的队列研究
J Clin Med. 2024 May 11;13(10):2829. doi: 10.3390/jcm13102829.
2
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy.阿哌沙班用于接受免疫调节治疗的多发性骨髓瘤患者静脉血栓栓塞的一级预防
Front Oncol. 2019 Feb 26;9:45. doi: 10.3389/fonc.2019.00045. eCollection 2019.
3
Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma.
多发性骨髓瘤中外泌体相关促凝磷脂和组织因子活性。
PLoS One. 2019 Jan 14;14(1):e0210835. doi: 10.1371/journal.pone.0210835. eCollection 2019.
4
Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.多发性骨髓瘤患者治疗前后血栓形成相关生物标志物的评估
J Blood Med. 2018 Jan 19;9:1-7. doi: 10.2147/JBM.S147743. eCollection 2018.
5
Assessment of oxidative/nitrative modifications of plasma proteins, selected ROTEM parameters and kinetics of fibrinogen polymerization in patients with multiple myeloma at diagnosis.多发性骨髓瘤患者诊断时血浆蛋白氧化/硝化修饰、选定的旋转血栓弹力图(ROTEM)参数及纤维蛋白原聚合动力学的评估
Med Oncol. 2017 Jan;34(1):4. doi: 10.1007/s12032-016-0856-3. Epub 2016 Nov 30.
6
The independent association of mean platelet volume with overall survival in multiple myeloma.平均血小板体积与多发性骨髓瘤总生存期的独立关联。
Oncotarget. 2016 Sep 20;7(38):62640-62646. doi: 10.18632/oncotarget.11551.